Bloomberg Gilead Sciences Inc agreed to pay $5.1 billion to raise its stake in Belgian biotechnology company Galapagos NV to deepen its research into inflammatory diseases and other disorders. The deal is the largest Gilead has executed since new Chief Executive Officer Dan O’Day took the reins in March as he attempts to bolster the San Francisco giant’s drug pipeline. ...

Bloomberg Finding a letter from the Church of England in his e-mail inbox was surprising enough for Vladimir Zaluzhsky, who’s in charge of investor relations at Russia’s second most valuable steelmaker. Even stranger was the demand to know what risks Severstal PJSC’s operations pose to the environment. The church’s pension board wanted details on how Severstal disposes of waste at ...

Bloomberg London house prices fell less than usual this month as sellers held back in a sign that the market may be stabilising, according to Rightmove. Home values in greater London slipped 0.2 percent, compared with an average 0.6 percent drop for July over the past five years, the property website said. From a year ago, prices slid 1.7 percent ...